Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer
Clinical trial NCT07172412 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07172412
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-12-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.